China’s First Domestically Produced Proton Therapy System Gained Approval For Marketing
2022-10-17
On Sep 26, 2022, NMPA approved the registration application of the innovative device “Proton Therapy System” produced by Shanghai APACTRON Particle Equipment Co., Ltd.
Consisting of the accelerator system and the therapy system, this device provides proton beams for radiotherapy. It is designed for the treatment of malignant solid tumors and certain benign diseases. Specific indications should be determined by clinicians according to the actual situation.
China has provided fast-track approvals for innovative medical devices. About 178 domestic and foreign innovative medical devices have been approved so far. The approval of the “Proton Therapy System” marks a new step in the localization of high-end medical devices in China and improves tumor diagnosis and treatment.
BradyKnows elite team provides turnkey solutions to innovative manufacturers from R&D, China entry strategy, registration, clinical evaluation and post-market surveillance.
If you have any questions on innovative pathway, please contact info@bradyknowsmedical.com. We would love to do more help on your China business.
